Day One Biopharmaceuticals, Inc.

19
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US23954D1090
USD
21.36
-0.08 (-0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
158.00
131.00
0.00
0.00
0.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
158.00
131.00
0.00
0.00
0.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
120.00
115.00
75.00
60.00
28.00
4.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
285.00
348.00
206.00
146.00
72.00
13.00
Operating Profit (PBDIT) excl Other Income
-127.00
-217.00
-206.00
-146.00
-72.00
-13.00
Other Income
18.00
128.00
17.00
4.00
0.00
0.00
Operating Profit (PBDIT)
-105.00
-86.00
-188.00
-141.00
-72.00
-13.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
3.00
2.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-109.00
-88.00
-188.00
-142.00
-72.00
-43.00
Provision for Tax
-1.00
7.00
0.00
0.00
0.00
0.00
Profit After Tax
-107.00
-95.00
-188.00
-142.00
-70.00
-40.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-1.04
-1.02
-2.37
-2.17
-2.75
-0.65
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 20.60% vs 0.00% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 41.20% vs -5.44% in Dec 2024

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -12.38% vs 49.45% in Dec 2024

Compare Profit and Loss Results of Day One Biopharmaceuticals, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
158.00
0.00
158.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
158.00
0.00
158.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
120.00
128.00
-8.00
-6.25%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
285.00
355.00
-70.00
-19.72%
Operating Profit (PBDIT) excl Other Income
-127.00
-355.00
228.00
64.23%
Other Income
18.00
25.00
-7.00
-28.00%
Operating Profit (PBDIT)
-105.00
-330.00
225.00
68.18%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
3.00
0.00
3.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-109.00
-169.00
60.00
35.50%
Provision for Tax
-1.00
0.00
-1.00
0%
Profit After Tax
-107.00
-169.00
62.00
36.69%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.0399
-0.3565
-0.68
-191.70%
Profit And Loss - Net Sales
Net Sales 158.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.60% vs 0.00% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -127.75 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 41.20% vs -5.44% in Dec 2024

Profit And Loss - Interest
Markets Mojo
No Interest in the last few periods
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax -107.32 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -12.38% vs 49.45% in Dec 2024